Literature DB >> 21418692

Seborrhoeic dermatitis.

Luigi Naldi1.   

Abstract

INTRODUCTION: Seborrhoeic dermatitis affects at least 10% of the population. Malassezia (Pityrosporum) ovale is thought to be the causative organism, and causes inflammation by still poorly defined mechanisms. Seborrhoeic dermatitis tends to relapse after treatment. METHODS AND OUTCOMES: We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of topical treatments for seborrhoeic dermatitis of the scalp in adults? What are the effects of topical treatments for seborrhoeic dermatitis of the face and body in adults? We searched: Medline, Embase, The Cochrane Library, and other important databases up to April 2010 (Clinical Evidence reviews are updated periodically, please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).
RESULTS: We found 12 systematic reviews, RCTs, or observational studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions.
CONCLUSIONS: In this systematic review we present information relating to the effectiveness and safety of the following interventions: bifonazole, emollients, ketoconazole, lithium succinate, selenium sulphide, tar shampoo, terbinafine, and topical corticosteroids (betamethasone valerate, clobetasol propionate, clobetasone butyrate, hydrocortisone, mometasone furoate).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21418692      PMCID: PMC3275327     

Source DB:  PubMed          Journal:  BMJ Clin Evid        ISSN: 1462-3846


  16 in total

1.  SEBORRHOEIC DERMATITIS IN ACUTE CARDIAC DISEASE.

Authors:  A TAGER; C BERLIN; R J SCHEN
Journal:  Br J Dermatol       Date:  1964 Aug-Sep       Impact factor: 9.302

2.  Skin lesions in chronic alcoholic pancreatitis.

Authors:  A Barba; W Piubello; I Vantini; S Caliari; R Cocchetto; P Vallaperta; L A Scuro; A Sapuppo; G Cavallini
Journal:  Dermatologica       Date:  1982-05

3.  Cutaneous disease and drug reactions in HIV infection.

Authors:  S A Coopman; R A Johnson; R Platt; R S Stern
Journal:  N Engl J Med       Date:  1993-06-10       Impact factor: 91.245

4.  A novel foam formulation of ketoconazole 2% for the treatment of seborrheic dermatitis on multiple body regions.

Authors:  Boni E Elewski; William Abramovits; Steven Kempers; Joel Schlessinger; Theodore Rosen; Aditya K Gupta; Sabra Abraham; Richard Rowell
Journal:  J Drugs Dermatol       Date:  2007-10       Impact factor: 2.114

5.  Use of topical lithium succinate in the treatment of seborrhoeic dermatitis.

Authors:  C Cuelenaere; J De Bersaques; A Kint
Journal:  Dermatology       Date:  1992       Impact factor: 5.366

6.  Comparative efficacy and safety of bifonazole 1% cream and the corresponding base preparation in the treatment of seborrhoeic dermatitis.

Authors:  H Zienicke; H C Korting; O Braun-Falco; I Effendy; M Hagedorn; B Küchmeister; C Meisel
Journal:  Mycoses       Date:  1993 Sep-Oct       Impact factor: 4.377

7.  Treatment of seborrhoeic dermatitis with ketoconazole: I. Response of seborrhoeic dermatitis of the scalp to topical ketoconazole.

Authors:  M M Carr; D M Pryce; F A Ive
Journal:  Br J Dermatol       Date:  1987-02       Impact factor: 9.302

8.  Treatment of seborrhoeic dermatitis with ketoconazole: II. Response of seborrhoeic dermatitis of the face, scalp and trunk to topical ketoconazole.

Authors:  C A Green; P M Farr; S Shuster
Journal:  Br J Dermatol       Date:  1987-02       Impact factor: 9.302

9.  Treatment with bifonazole shampoo for seborrhea and seborrheic dermatitis: a randomized, double-blind study.

Authors:  R Segal; M David; A Ingber; R Lurie; M Sandbank
Journal:  Acta Derm Venereol       Date:  1992-11       Impact factor: 4.437

10.  A randomized, double-blind, placebo-controlled trial of ketoconazole 2% shampoo versus selenium sulfide 2.5% shampoo in the treatment of moderate to severe dandruff.

Authors:  F W Danby; W S Maddin; L J Margesson; D Rosenthal
Journal:  J Am Acad Dermatol       Date:  1993-12       Impact factor: 11.527

View more
  6 in total

Review 1.  Hydrogel-Based Active Substance Release Systems for Cosmetology and Dermatology Application: A Review.

Authors:  Martyna Zagórska-Dziok; Marcin Sobczak
Journal:  Pharmaceutics       Date:  2020-04-26       Impact factor: 6.321

2.  Evaluation of a Topical Anti-inflammatory/Antifungal Combination Cream in Mild-to-moderate Facial Seborrheic Dermatitis: An Intra-subject Controlled Trial Examining Treated vs. Untreated Skin Utilizing Clinical Features and Erythema-directed Digital Photography.

Authors:  Federica Dall'Oglio; Aurora Tedeschi; Vincenzo Guardabasso; Giuseppe Micali
Journal:  J Clin Aesthet Dermatol       Date:  2015-09

3.  Noncorticosteroid Combination Shampoo versus 1% Ketoconazole Shampoo for the Management of Mild-to-Moderate Seborrheic Dermatitis of the Scalp: Results from a Randomized, Investigator-Single-Blind Trial Using Clinical and Trichoscopic Evaluation.

Authors:  Federica Dall'Oglio; Francesco Lacarrubba; Anna Elisa Verzì; Giuseppe Micali
Journal:  Skin Appendage Disord       Date:  2015-10-17

Review 4.  Therapy of Skin, Hair and Nail Fungal Infections.

Authors:  Roderick Hay
Journal:  J Fungi (Basel)       Date:  2018-08-20

Review 5.  Topical Non-Pharmacological Treatment for Facial Seborrheic Dermatitis.

Authors:  Jaime Piquero-Casals; Doris Hexsel; Juan Francisco Mir-Bonafé; Eduardo Rozas-Muñoz
Journal:  Dermatol Ther (Heidelb)       Date:  2019-08-08

6.  Prevalence and Associated Diseases of Seborrheic Skin in Adults.

Authors:  Natalia Kirsten; Nicole Mohr; Aminah Alhumam; Matthias Augustin
Journal:  Clin Epidemiol       Date:  2021-09-18       Impact factor: 4.790

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.